ESC/EAS = European Society of Cardiology / European Atherosclerosis Society. They publish influential guidelines for managing dyslipidaemia (abnormal cholesterol and lipid levels in the blood).
Level 1a Recommendation = The strongest possible guideline recommendation. It means there’s solid clinical evidence from multiple high-quality studies and that the treatment is strongly advised in clinical practice.
It’s a big win for Esperion, because being included with a Level 1a recommendation in the ESC/EAS guidelines boosts physician confidence and can drive wider adoption of Bempedoic Acid in Europe and globally.